GlassScriptPhysician profile
Gene Joseph Braga
NPI 1336118835
$8,404.18
in general payments reported to CMS, 2019-2025
49 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $846 · 2021: $1,097 · 2022: $1,636 · 2023: $1,837 · 2024: $1,206 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,136 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,135.50 |
| Education | $124.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,149.56 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $883.61 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $764.50 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Abbvie INC. | $629.17 | 2019-2025 | Lupron Depot |
| Teleflex LLC | $623.56 | 2023-2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $418.96 | 2019-2025 | |
| Urovant Sciences INC | $411.02 | 2021-2022 | |
| Pfizer INC. | $388.18 | 2019-2025 | |
| Tolmar, INC. | $311.94 | 2023-2025 | Eligard, Jatenzo, Rubraca |
| Myovant Sciences INC. | $274.17 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $220.14 | 2021-2024 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $185.20 | 2020-2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $152.50 | 2023-2025 | Pylarify |
| Integra Lifesciences Corporation | $145.86 | 2020 | |
| 180 Medical, INC. | $144.33 | 2019-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Braga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.